相关实验视频

Updated: Jun 28, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

用基因组工具增强乳腺癌的临床决策支持:苏格兰的观点

A L Peters¹, P S Hall², L B Jordan³

¹Beatson West of Scotland Cancer Centre, Gartnavel Hospital, NHS Greater Glasgow & Clyde, 1053 Great Western Rd, Glasgow G12 0YN, UK; Cancer Research UK (CRUK) Scotland Institute, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Breast (Edinburgh, Scotland)

|April 24, 2024

概括

瘤型DX乳腺复发评分 (RS) 测试显著改变了苏格兰的化疗决策,减少了对高风险患者的使用,并确定了其他受益者. 孕激素受体状态独立预测RS结果.

科学领域:

在瘤学瘤学.
基因组医学是基因组医学.
临床实践研究临床实践研究

背景情况:

在苏格兰,瘤型DX乳腺复发分数 (RS) 测试已被采用.
一项以人口为基础的研究评估了RS测试的摄入量,相关共变量和临床实践影响.
苏格兰健康改善局 (HIS) 更新了有关RS测试在苏格兰NHS使用的指南.

研究的目的:

评估苏格兰对型DX乳腺RS测试的采用情况.
为了识别与RS相关的共变量.
分析RS测试对临床实践和化疗施用的影响.

主要方法:

一项泛苏格兰研究分析了2018年8月至2021年8月期间833名患者的数据.
从电子记录中追溯地提取数据.
分析包括与传统风险评估工具的直接比较和单变量/多变量回归来评估共变量和RS之间的关系.

主要成果:

化疗的使用受到RS的强烈影响 (p < 0.001).
55.5%具有高风险PREDICT评分的患者RS值较低,并且没有接受化疗.
孕激素受体Allred评分 (PR评分) 是高RS的强有力的独立预测指标 (OR4.49,p < 0.001);升级也与高RS相关 (OR3.81,p < 0.001).

结论:

在苏格兰实施RS测试显著减少了化疗的使用,特别是在具有较低RS结果的高风险PREDICT组.
该测试还确定了一组低风险的PREDICT患者的亚组,这些高RS患者从化疗中受益.
公共关系得分显示出与高RS具有强烈的独立关联,这表明需要进一步研究的潜在预后价值.

关键词:

乳腺癌是什么? 乳腺癌是什么化疗化疗是一种化学疗法.孕激素受体是什么? 孕激素受体是什么?复发性得分复发性得分复发性得分基因组测试是基因组测试.

更多相关视频

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...